Page 35 - SOGBA_1_2022
P. 35

Meeting. Eur J Endocrinol. septiem-      tes and residual risk for a postnatal
            bre de 2017;177(3):G1–70.                diagnosis of an atypical chromoso-
          10.  Malvestiti F, Agrati C, Grimi B, Pom-  me aberration following combined
            pilii E, Izzi C, Martinoni L, et al. In-  first-trimester   screening.   Prenat
            terpreting mosaicism  in  chorionic      Diagn. junio de 2020;40(7):852–9.
            villi: results of a monocentric series   16.  Ge Y, Li J, Zhuang J, Zhang J, Huang
            of  1001 mosaics  in chorionic  villi    Y, Tan M, et al. Expanded noninva-
            with follow-up amniocentesis:  In-       sive prenatal testing for fetal aneu-
            terpreting mosaicism  in  chorionic      ploidy and copy number variations
            villi. Prenat Diagn. noviembre de        and parental willingness for invasi-
            2015;35(11):1117–27.                     ve diagnosis in a cohort of 18,516 ca-
          11.  Viuff M, Skakkebæk A, Nielsen MM,     ses. BMC Med Genomics. diciembre
            Chang S, Gravholt CH. Epigenetics        de 2021;14(1):106.
            and genomics in Turner syndrome.       17.  Christiaens  L,  Chitty  LS,  Langlois
            Am J Med Genet C Semin Med Ge-           S. Current controversies in prena-
            net. marzo de 2019;181(1):125–32.        tal diagnosis: Expanded NIPT that
          12.  Viuff  MH,  Stochholm  K,  Uldbjerg   includes conditions otherthan triso-
            N, Nielsen BB, the Danish Fetal Me-      mies 13, 18, and 21 should be offe-
            dicine Study Group,  Gravholt  CH.       red. :22.
            Only a minority of sex chromosome      18.  Bedei I, Wolter A, Weber A, Signore
            abnormalities are detected by a na-      F, Axt-Fliedner R. Chances and Cha-
            tional prenatal screening program        llenges of New Genetic Screening
            for Down syndrome. Hum Reprod.           Technologies (NIPT) in Prenatal Me-
            octubre de 2015;30(10):2419–26.          dicine from a Clinical Perspective: A
          13.  Gadsbøll K, Petersen OB, Gatinois     Narrative Review. Genes. 29 de mar-
            V, Strange H, Jacobsson  B, Wapner       zo de 2021;12(4):501.
            R, et al. Current use of noninvasive   19.  Schmid M, Klaritsch P,  Arzt W,
            prenatal testing in Europe, Australia    Burkhardt T, Duba H, Häusler M,
            and the USA: A graphical presenta-       et al. Cell-Free DNA Testing for Fe-
            tion. Acta Obstet Gynecol Scand. ju-     tal Chromosomal Anomalies in clini-
            nio de 2020;99(6):722–30.                cal practice: Austrian-German-Swiss
          14.  Gil MM, Accurti V, Santacruz B, Pla-  Recommendations  for  non-invasive
            na MN, Nicolaides KH. Analysis of        prenatal tests (NIPT).  Ultraschall
            cell-free DNA in maternal blood in       Med - Eur J Ultrasound. 15 de octu-
            screening for aneuploidies: upda-        bre de 2015;36(05):507–10.
            ted meta-analysis: Cell-free DNA in    20.  Bianchi DW. Turner syndrome: New
            screening for aneuploidies. Ultra-       insights from prenatal genomics
            sound  Obstet Gynecol. septiembre        and transcriptomics. Am J Med Ge-
            de 2017;50(3):302–14.                    net C  Semin  Med  Genet. marzo  de
          15.  Iwarsson E, Conner P. Detection ra-   2019;181(1):29–33.



          Vol. 53 -  Nº 257 / 1 - Año 2022                                                                                                                                           33
   30   31   32   33   34   35   36   37   38   39   40